Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cohesion Technologies (NasdaqNM:CSON)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug 27Price hit new 52-week low ($2.04)
Aug  8Earnings Announcement
Location
2500 Faber Place
Palo Alto, CA 94303
Phone: (650) 320-5500
Fax: (650) 320-5522
Email: admin@cohesiontech.com
Employees (last reported count): 77
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 32%
·Over the last 6 months:
 · one insider buy; 5,000  shares (0.2% of insider shares)
·Institutional: 23% (33% of float)
(29 institutions)
·Net Inst. Selling: 51.0K shares (+2.44%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cohesion Technologies, Inc. is focused on developing and commercializing proprietary surgical products, including bioresorbable hemostatic devices and biosealants for tissue repair and regeneration, which increase the effectiveness of, and minimize complications following, open and minimally invasive surgeries. CoStasis Surgical Hemostat, the Company's hemostatic product, is designed for use in cardiovascular, orthopedic and general surgery indications. The Company's CoSeal Surgical Sealant, its lead biosealant product candidate, is designed for sealing vascular grafts and other tissues. The Company received European Community certification for CoStasis in fiscal 1999, and in June 2000, the Company received approval from the FDA to market CoStasis in the United States. The Company received CE Mark in February 2000 for CoSeal Surgical Sealant and is currently conducting clinical trials in the United States.
More from Market Guide: Expanded Business Description

Financial Summary
Cohesion Technologies, Inc. develops and commercializes proprietary surgical products for tissue repair and regeneration which increase the effectiveness of and minimize complications following invasive surgeries. For the fiscal year ended 6/30/01, revenues rose 19% to $3 million. Net loss before acct. change totalled $12.1 million, vs. an income of $8.9 million. Results reflect increased Costasis sales which commenced in 7/00, offset by decreased gains on investments.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

John Daniels, M.D., 62
Chairman
--  --  
David Foster, 43
CEO, Director
$194K$47K
Frank DeLustro, Ph.D., 52
Pres, COO, Director
194K164K
Deborah Webster, 41
VP and CAO
167K25K
Russell McDaniell, 51
VP of Sales
163K--  
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CSONAs of 31-Aug-2001
Price and Volume
52-Week Low
on 27-Aug-2001
$2.04 
Recent Price$2.872
52-Week High
on 5-Sep-2000
$12.00 
Beta1.72 
Daily Volume (3-month avg)36.0K
Daily Volume (10-day avg)72.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-73.9%
52-Week Change
relative to S&P500
-65.0%
Share-Related Items
Market Capitalization$26.9M
Shares Outstanding9.37M
Float6.40M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.26 
Earnings (ttm)-$1.30 
Earnings (mrq)-$0.19 
Sales (ttm)$0.32 
Cash (mrq)$1.08 
Valuation Ratios
Price/Book (mrq)0.88 
Price/EarningsN/A 
Price/Sales (ttm)8.98 
Income Statements
Sales (ttm)$2.98M
EBITDA (ttm)-$20.3M
Income available to common (ttm)-$12.1M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-22.20%
Return on Equity (ttm)-31.93%
Financial Strength
Current Ratio (mrq)3.25 
Debt/Equity (mrq)0.03 
Total Cash (mrq)$10.1M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
3,000 
Daily Volume22.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.